Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
HUGO Series 🌟
HUGO-GT™ (Humanized Genomic Ortholog)
HUGO-Ab™ (Humanized Genomic Ortholog for Antibody)
MouseAtlas Model Library
Flash Sales
Research Models
Cre Mouse Lines
Humanized Target Gene Models
Metabolic Disease Models
Ophthalmic Disease Models
Neurological Disease Models
Autoimmune Disease Models
Immunodeficient Mouse Models
Humanized Immune System Mouse Models
Oncology & Immuno-oncology Models
Covid-19 Mouse Models
Cell Line Models
Knockout Cell Line Product Catalog
Tumor Cell Line Product Catalog
iPSC Cell Line Product Catalog
AAV Standard Product Catalog
Services
Preclinical Efficacy
Neuroscience
Alzheimer's Disease (AD)
Parkinson's Disease (PD)
Huntington's Disease (HD)
Ophthalmology
Glaucoma
Age-Related Macular Degeneration (AMD)
Oncology
PBMC Humanized Mouse Models
Human Immune System (HIS) Mouse Model
Metabolic & Cardiovascular Diseases
Anti-Obesity
Autoimmune & Inflammatory
Asthma
Genetically Engineered Animals
Knockout Mice
Transgenic Mice
Knockin Mice
Knockout Rats
Knockin Rats
Transgenic Rats
Model Generation Techniques
Turboknockoutᵀᴹ Gene Targeting
Cre-ESCs Gene Editing
Targeted Gene Editing
Regular Transgenic
PiggyBac Transgenesis
BAC Transgenic
Breeding & Supporting Services
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
BAC Modification
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Lentivirus Packaging
Adenovirus Packaging
Custom Cell Line Services
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Point Mutation Cell Lines
Overexpression Cell Lines
Modalities
Gene Therapy
AI-Powered AAV Discovery
Oligonucleotide Therapy
Cell Immunotherapy
Resources
Promotion
Events & Webinars
Newsroom
Blogs & Insights
Resource Vault
Reference Databases
Peer-Reviewed Citations
Rare Disease Data Center
AbSeek
Cell iGeneEditor™ System
OriCell Cell Culture
About Us
Corporate Overview
Facility Overview
Animal Health & Welfare
Health Reports
Our Team
Our Partners
Careers
Contact Us
Login
Blogs & Insights
Explore the latest in biotech and research, crafted to inspire your next breakthrough.
Metabolism & Obesity
HFD+CCl4-Induced Metabolic Dysfunction-Associated Steatohepatitis (MASH/NASH) Mice
Ophthalmology
Vision Stolen by Years - Age-related Macular Degeneration
Rare Diseases
Pathogenic Genes of Rare Disease - SMN1 in Spinal Muscular Atrophy Research
Top Reads
Metabolism & Obesity
HFD+CCl4-Induced Metabolic Dysfunction-Associated Steatohepatitis (MASH/NASH) Mice
View Details
Ophthalmology
Vision Stolen by Years - Age-related Macular Degeneration
View Details
Rare Diseases
Pathogenic Genes of Rare Disease - SMN1 in Spinal Muscular Atrophy Research
View Details
New Updates
STEAP2 in Prostate Cancer: AstraZeneca’s Multi-Modality Bet on a Next-Wave Target
View Details
Proteasome-guided haem signalling axis contributes to T cell exhaustion: Preclinical validation powered by Cyagen’s NKG mice
View Details
ARVO 2026: Achieving Precision Ophthalmology with Nucleic Acid Therapeutics and Advanced Preclinical Models
View Details
From Uric Acid Metabolism to Gouty Inflammation: Model Strategies for Preclinical Research
View Details
Ready to Elevate Your Research?
Discover how Cyagen can support your research. Let’s start a conversation.
Filter By
All Topics
Animal Science and Quality
Autoimmunity & Inflammation
Cardiovascular Research
Cell & Gene Therapy
Genetic Disorders and Genomics
Immunology
Infectious Diseases & Vaccines
Metabolism & Obesity
Neuroscience
Oncology
Ophthalmology
Precision Medicine & Biomarkers
Rare Diseases
Regenerative Biology
Milestones & Highlights
Filter By
Oncology
STEAP2 in Prostate Cancer: AstraZeneca’s Multi-Modality Bet on a Next-Wave Target
View Details
Autoimmunity & Inflammation
Proteasome-guided haem signalling axis contributes to T cell exhaustion: Preclinical validation powered by Cyagen’s NKG mice
View Details
Metabolism & Obesity
From Uric Acid Metabolism to Gouty Inflammation: Model Strategies for Preclinical Research
View Details
Ophthalmology
ARVO 2026: Achieving Precision Ophthalmology with Nucleic Acid Therapeutics and Advanced Preclinical Models
View Details
Rare Diseases
Hemophilia Gene Therapy & Next-Gen Treatments: F8/F9 Humanized Mouse Models for Preclinical Validation
View Details
Immunology
Breaking the COPD Bottleneck: IL-33/ST2/IL1RAP Breakthroughs and the Power of Humanized Models
View Details
Oncology
Understanding Athymic Nude Mice: Foxn1 Genetics, Immunology and Oncology CDX Applications
View Details
Cell & Gene Therapy
Targeted AAV Delivery Strategies for Adipose Tissue: From the Discovery of the Novel BAT Target to In Vivo Validation
View Details
Neuroscience
Lessons from the Lilly-AC Immune Expansion: Is the "Extracellular Tau Antibody" Era Over?
View Details
1
2
3
4
5
6
...
18
19
More
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0336
Email:
inquiry@cyagen.com
Models
HUGO-Ab™ (Humanized Genomic Ortholog for Antibody)HUGO-GT™ (Humanized Genomic Ortholog)MouseAtlas Model LibraryResearch Models
Services
NeuroscienceOphthalmologyOncologyMetabolic & Cardiovascular DiseasesAutoimmune & Inflammatory
About Us
Corporate OverviewFacility OverviewAnimal Health & WelfareHealth ReportsOur PartnersCareersContact Us
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Global Antibody Drug Industry Development BlueBook (Frost & Sullivan)
Key Insights
The industry is undergoing a rapid transformation driven by next-generation modalities, globalized markets, and upstream technological innovations.
  • Market Structural Shift: Monoclonal antibodies drive steady growth, but ADCs and bispecifics are rapidly accelerating, reshaping the market with higher-value innovations.
  • Chinese Market Globalization: China is actively expanding globally, evidenced by a surge in high-value cross-border license-out deals.
  • Technology-Driven Efficiency: Advanced discovery engines—exemplified by Cyagen's HUGO-Ab platform and AI algorithms—are streamlining candidate screening, optimizing molecular design, and localizing the upstream supply chain.
  • Oncology-Focused Innovation: R&D pipelines remain heavily concentrated on high-incidence malignancies like non-small cell lung cancer, utilizing complex modalities to combat clinical resistance.
Now Available for Download
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest
Main Area of Research